Aeglea Biotherapeutics shares owned by Sugar Maple Asset Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Sugar Maple Asset Management
from 13F filings
Historical chart of Sugar Maple Asset Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Sugar Maple Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aeglea Biotherapeutics by Sugar Maple Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $4.2k | 180 | 23.28 |
More positions owned by Sugar Maple Asset Management
View all positions for Sugar Maple Asset Management